Topic

Articles

Series Part 3—Methods for early detection of risk and summary.

Defining Quality Tolerance Limits and Key Risk Indicators that Detect Risks in a Timely Manner: Reflections from Early Adopters on Emerging Best Practices (Part 3)

Series Part 2—The process of defining QTLs.

Defining Quality Tolerance Limits and Key Risk Indicators that Detect Risks in a Timely Manner: Reflections from Early Adopters on Emerging Best Practices (Part 2)

Series Part 1—Introduction and the relationship between QTL and KRI.

Defining Quality Tolerance Limits and Key Risk Indicators that Detect Risks in a Timely Manner: Reflections from Early Adopters on Emerging Best Practices (Part 1)

With large shift to decentralized strategies, industry roles appear set for change.

Salary Survey: The Age of COVID

Clinical Trials Salary and Satisfaction Survey, January 2020

The perfect storm of industry growth, opportunity, and demand is translating to solid salary and satisfaction levels among clinical trial professionals, according to new survey.

Salary Survey: A Healthy Trajectory for Clinical Research Professionals

Reference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.

CDISC Glossary of Clinical Research Terminology

The Clinical Endpoints Adjudication Group and Ethical Clinical designed and implemented an industry survey to evaluate factors that drive the use of endpoint adjudication in clinical trials.

Endpoint Adjudication and the ICH E6

The standardization of trial metrics offers numerous benefits towards overseeing clinical trials, optimizing clinical operations and mitigating study risks. However, on a situational basis customized metrics may become necessary to address study-specific risks, uncover unknown issues and demonstrate results.

Standardized Metrics Capture Most, Not All Clinical Trial Risks

Due to mistakes by research professionals, clinical trials have been subject to delays or even cancellations. The National Board of Medical Examiners is working to reverse this trend by introducing an assessment to test the knowledge of clinical researchers.

Metrics and Benchmarks